Document is current
Any future updates will be listed below
-
Authors
Kang, Jongkyun
Shen, Jie
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS041783)
- License Information
-
More Information
Article History
Received: 30 June 2020
Accepted: 1 December 2020
First Online: 10 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: J.S. is a member of the Board of Directors and has a financial interest in iNeuro Therapeutics, and J.S. also has a financial interest in Apres Therapeutics. Both companies develop therapies for Alzheimer’s disease. J.S.’s interests were reviewed and are managed by BWH and Partners HealthCare in accordance with their conflict of interest policies.
